C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/2004
12/08/2004	CN1553909A Benzimidazole and pyridylimidazole derivatives as ligands for GABA receptors
12/08/2004	CN1553802A 喜树碱衍生物 Camptothecin derivatives
12/08/2004	CN1552712A New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them
12/07/2004	US6828343 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
12/07/2004	US6828342 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment
12/07/2004	US6828319 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/07/2004	CA2287736C Furopyridine antibacterials
12/07/2004	CA2134608C Indole derivatives, salts thereof, and heart affection therapeutic agent comprising the same
12/02/2004	WO2004104009A1 Process for making spirolactone compounds
12/02/2004	WO2004103978A1 2-substituted pyrimidines
12/02/2004	WO2004103967A2 Thiocarbamate inhibitors of alpha-4 integrins
12/02/2004	WO2004103305A2 Spiropyrazole compound
12/02/2004	WO2004103276A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/02/2004	WO2004072031A3 Phenylacetamides and their use as glucokinase modulators
12/02/2004	WO2004069840A3 Production of tetrahydroquinoline benzofurans
12/02/2004	US20040242928 Reverse hydroxamic acid derivatives
12/02/2004	US20040242902 Labeling Dna in automatic sequencing; bar codes; lipid solubility
12/02/2004	US20040242856 Reverse color when radiated with light
12/02/2004	US20040242664 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
12/02/2004	US20040242662 Azinyl sulfonylimidazoles for use as microbicidal agents
12/02/2004	US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004	US20040242622 Azabicycloalkane compounds
12/02/2004	US20040242609 Therapy for eating disorders, sexual disorders, psychological disorders
12/02/2004	US20040242595 Pyrimidine derivatives
12/02/2004	US20040242573 Novel compounds
12/02/2004	US20040242564 1,2,3,4-tetrahydroisoquinolines derivatives
12/02/2004	US20040242554 Eating disorders; cognition activators; psychological disorders; anxiolytic agents; sexual disorders; incontinence; antidepressants
12/02/2004	US20040242533 such as 5-iodo-O6-5'-cyclo-5,6-dihydro-3'-azido-3'-deoxythymidine for prophylaxis or diagnosis of viral diseases caused by hepatitis virus, herpes viruses such as Epstein-Barr virus
12/02/2004	CA2526027A1 Process for making spirolactone compounds
12/02/2004	CA2525934A1 Thiocarbamate inhibitors of alpha-4 integrins
12/02/2004	CA2525762A1 2-substituted pyrimidines
12/02/2004	CA2524531A1 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/01/2004	EP1481975A1 Inhibitors of farnesyl protein transferase
12/01/2004	EP1481970A1 Novel herbicides
12/01/2004	EP1481679A1 Antidepressant
12/01/2004	EP1480984A2 Condensed camptothecins as antitumor agents
12/01/2004	EP1480973A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
12/01/2004	EP1246625B1 Uses and compositions of nitrate esters for providing sedation
12/01/2004	EP0808316B9 Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines
12/01/2004	CN1551770A Sustained release formulations of oxymorphone
12/01/2004	CN1177850C Camptothecin analogs and methods of preparation thereof
12/01/2004	CN1177847C Oxazolidines compounds as 5-HT2A-antagonists
11/2004
11/30/2004	US6825351 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (r)- and (s)-forms
11/30/2004	US6825213 β3-adrenoreceptor agonists, agonist compositions and methods of using
11/30/2004	US6825207 Anticancer agents
11/30/2004	US6825206 Treatment of leukemia, solid tumors and brain glioma in mammals using the conjugates
11/30/2004	US6825194 Hexacyclic compounds
11/30/2004	US6825176 Synthesis and use of a probe that binds with specificity to the transactivation domain (tad) of human papillomavirus (hpv) e2 to form a complex, which is capable of being displaced by inhibitors of hpv
11/30/2004	US6825166 Molecular conjugates for use in treatment of cancer
11/25/2004	WO2004101709A1 Phenyl xanthene dyes
11/25/2004	WO2004101558A1 2-imidazo-benzothiazoles as adenosine receptor ligands
11/25/2004	WO2004100947A2 Novel chemical compounds
11/25/2004	WO2004100897A2 Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin
11/25/2004	WO2004100891A2 Cytotoxic indeno and isoindoloisoquinolones
11/25/2004	WO2004100888A2 N-thiolated azetidinones and anti-cancer use thereof
11/25/2004	WO2004073610A3 Estrogen receptor modulators
11/25/2004	WO2004062629A3 Apoptolidin analogs and derivatives for inducing apoptosis in transformed cells
11/25/2004	WO2004047755A3 Fused bicyclic nitrogen-containing heterocycles
11/25/2004	WO2004034972A3 Compounds, compositions, and methods
11/25/2004	WO2004007407A3 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
11/25/2004	US20040235926 such as 1-[2-(2-chloro-phenyl)-3-(4-fluoro-phenyl)-2H-pyrazolo[3,4-d]pyridazin-7-yl]-4-isopropylamino-piperidine-4-carboxylic acid amide; for treatment of eating disorders and psychological disorders
11/25/2004	US20040235915 Benzothiazole derivatives
11/25/2004	US20040235886 Gyrase inhibitors and uses thereof
11/25/2004	US20040235884 increasing choline transporters on the cell membrane of nervous systems by administering drugs such as 2-(2-oxopyrrolidin-1-yl)-N-(2,3dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4yl)acetamide; prophylaxis of nervous system disorders
11/25/2004	US20040235883 Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
11/25/2004	US20040235882 compounds such as (8R,9R)-2,3-Dimethyl-9-phenyl-8-pivaloyloxy-7,8,9,10-tetrahydroimidazo[1.2-h][1.7]naphthyridin-7-one, used as antisecretory agents
11/25/2004	US20040235878 7-ethyl-20(S)-camptothecin; reduction and subsequent oxidation of chemical intermediates to form Irinotecan; catalysis
11/25/2004	US20040235867 Drugs used for signal transduction modulation, and for prophylaxis of angiogenesis, cancers, tumors, atherosclerosis, vision disorders and inflammatory diseases in mammals
11/25/2004	US20040235851 Nitrogen compounds such as 6-[4-(5-Fluoro-1H-indol-3-yl)-3,6-dihydro-2H-pyridin-1-ylmethyl]-7,8-dihydro-6H-5-oxa-1aza-phenanthrene and/or stereoisomers, used as serotonin receptor antagonists; anxiolytic agents
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235750 Thiocarbamate inhibitors of alpha-4 integrins
11/25/2004	US20040234957 Compositions and methods for labeling oligonucleotides
11/25/2004	DE10320453A1 Neue Bioisostere von Actinonin New bioisosteres of Actinonin
11/25/2004	DE10320351A1 Production of a coated support by stepwise synthesis of a receptor comprising a linker and probe comprises monitoring the synthesis by incorporating one or more labeled synthesis units into the linker and the probe
11/25/2004	CA2525099A1 Cytotoxic indeno and isoindoloisoquinolones
11/25/2004	CA2523959A1 2-imidazo-benzothiazoles as adenosine receptor ligands
11/25/2004	CA2523059A1 Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin
11/24/2004	EP1479681A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE
11/24/2004	EP1479397A1 2,4,6-triamino-1,3,5-triazine derivative
11/24/2004	EP1478648A2 Phosphorus-containing compounds uses thereof
11/24/2004	EP1478645A2 Quinolinone derivatives for treating cell proliferation related disorders
11/24/2004	EP1478639A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/24/2004	EP1185536B1 Hemisynthetic method and intermediates thereof
11/24/2004	EP0976732B1 1,4-substituted cyclic amine derivatives
11/24/2004	CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1176923C Technological process for producing camptothecine and 10-hydroxycamptothecine
11/23/2004	US6822097 Compounds and methods of uses
11/23/2004	US6821982 Preparation of a camptothecin derivative by intramolecular cyclisation
11/23/2004	US6821981 For therapy of disorders, such as anxiety, aggression and stress, and for the control of various physiological phenomena, such as appetite, thermoregulation, sleep and sexual behavior
11/23/2004	US6821971 For prophyalxis of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease (ibs), septic shock, cardiopulmonary dysfunction, acute respiratory disease, cachexia
11/23/2004	CA2329788C Quinoline derivatives
11/18/2004	WO2004099215A1 Use of vinca alkaloid and its salt
11/18/2004	WO2004099214A1 Quinoline 3-amino chroman derivatives
11/18/2004	WO2004099203A1 Imidazopyridine intermediates
11/18/2004	WO2004099176A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
11/18/2004	WO2004099164A1 Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating hcv infection
11/18/2004	WO2004099157A1 Cannabinoid receptor ligands and uses thereof
11/18/2004	WO2004099124A2 Novel bioisosteres of actinonin
11/18/2004	WO2004012661A3 Novel anticancer conjugates of camptothecin and unsaturated fatty acids

1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 298